, a medication that was used in nearly two-thirds of all abortions in the U.S. last year, in the court’s first abortion case since conservative justices overturnedthat abortion opponents who challenged the the Food and Drug Administration's approval of the medication, and subsequent actions to ease access to it, lack the legal right or standing to sue.The FDA approved mifepristone in 2000 as a safe and effective way to end early pregnancies.
Hawley pointed out that FDA’s own prescribing label mentions that 2.9% to 4.6% of women taking the drug go to the emergency room. But Solicitor General Elizabeth Prelogar pointed to studies showing that half of women who go to the emergency room don’t get any treatment at all.“Many women might go because they’re experiencing heavy bleeding, which mimics a miscarriage, and they might just need to know whether or not they’re having a complication,” Prelogar said.
The FDA permanently lifted one of its restrictions on how patients are able to access Mifeprex, one of two medicines commonly prescribed for medical abortions.